Yahoo
OTC Markets OTCID USD

Regen BioPharma, Inc. (RGBP)

0.0002 -0.0000 (-25.00%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Cash Flow from Operating Activities, Indirect
-445.2490 -383.5910 -751.5360 -173.9170 -606.9210
Cash Flow from Investing Activities
-- -- -- -- 25
Cash Flow from Financing Activities
443.7260 452.4300 631.2150 243.7500 -94.0360
Cash and Cash Equivalents, End of Period
0.2390 69.5550 0.7160 121.0370 51.2040
Cash Flow, Supplemental
Free Cash Flow to Firm
253.3830 -- -395.7090 -337.7140 2,696.2247
Issuance of Capital Stock
300 -- 563.7220 0 0
Repurchase of Capital Stock
0 -- 0 0 0
Free Cash Flow to Cash Flow from Operating Activities
1.00 -- -- 1.00 1.00
9/30/2022 - 10/6/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: